2025年12月6日~9日，第67届美国血液学会年会（ASH）年会将在美国奥兰多举行，本次会议将采用线上与线下相结合的形式，进一步提升会议的全球参与度和学术影响力。日前，ASH官网公布了本次会议的详细日程。【肿瘤资讯】特将各专场的精要内容整理成中英文版本，以飨读者。
一、专场名称及缩写
摘要专场（Abstract Sessions）
Oral Abstract Sessions：口头报告专场
Late-Breaking Abstract Sessions：突破性研究专场
Poster Presentations：海报展示
教育项目（Education Program）
Education Program Sessions：教育项目专场
Education Spotlight Sessions：焦点讨论专场
How I Treat Sessions：“我如何治疗”专场
科学项目（Scientific Program）
Scientific Program Sessions：科学项目专场
Scientific Spotlight Sessions：焦点讨论专场
Meet the Scientist Sessions：科学家见面会
Scientific Symposia：科学研讨会-演讲
Scientific Workshops：科学研讨会-互动
ASH Poster Walks：ASH 海报展
特别兴趣专题会（Special Interest Sessions and Studios）
Special Interest Sessions：特别兴趣专场
Population Health Sessions：人口健康会议
ASH Wellness Studio：ASH 健康工作室
Blood Journals Studio：血液期刊工作室
ASH Studio：ASH工作室
二、时区与时差
2025ASH年会举办地点为美国奥兰多，地处美国东部时区（UTC-5），与地处东八区（GMT+8）的北京时间相差13个小时。
例如，当地时间12月6日7:00 A.M，即为北京时间12月6日20:00。
三、不可避免的信息差
ASH大会日程可能会根据实际情况进行调整，故详情请以后续的最新报道内容或官网的最新发布内容为准。
中文日程（GMT+8时区）
以下均为北京时间，GMT+8
2025年12月6日（周六）
20:00 – 次日07:00
现场注册开放
21:00 – 22:00
“我如何治疗”专场
动脉血栓的应对策略：血液科医师的视角
免疫治疗时代，我如何治疗B-急性淋巴细胞白血病的孤立性中枢神经系统复发
我如何治疗前线四联疗法后的多发性骨髓瘤进展
我如何平衡血红蛋白病抗凝管理的风险与收益
我如何在造血干细胞移植与细胞治疗前后应用下一代测序技术
科学家见面会
基因组学与儿童急性白血病的靶向治疗
骨髓瘤生物学与治疗
移植之路勿独行：全面管理策略
骨髓衰竭综合征中的体细胞遗传救援——是敌是友？
企业演示： 产品展厅
21:00 – 次日08:30
海报专场 I
22:30 – 23:45
教育项目专场
不明原因出血性疾病——我们已知什么？
免疫性血细胞减少症：应对挑战与治疗进展
科学项目专场
解析增强子在造血发育与疾病中的功能
探索多发性骨髓瘤的起源：胚系易感性与早期失调铁与血红素代谢及其在病理生理与治疗中的考量
改善造血细胞移植与过继性细胞疗法后预后的策略
特别兴趣专场
利用临床前发现的遗传多样性指导精准医疗
22:30 – 次日00:00
口头报告专场
特别兴趣专场
利用镰状细胞病的真实世界数据识别与研究特定队列
次日00:15 – 01:15
特别兴趣专场
Blood 杂志推介：如何在同行评审期刊上发表论文
ASH 海报展（由Blood Vessels, Thrombosis & Hemostasis主办）
次日00:30 – 01:30
企业演示： 产品展厅和行业展厅
次日01:00 – 02:30
口头报告专场
次日01:30 – 02:30
Ham-Wasserman 讲座
次日03:00 – 04:15
教育项目专场
补体病：现代诊断与管理
免疫介导性和先天性TTP患者护理格局的变迁
深入探索：组织细胞疾病的更新
B-急性淋巴细胞白血病前线治疗中免疫靶向药物的整合：成功与挑战
当下正是改善弥漫大B细胞淋巴瘤预后的时机
科学项目专场
开启开关：胎儿血红蛋白再活化治疗血红蛋白病——从机制到疗法
淋巴瘤的创新模型
次日03:00 – 04:30
口头报告专场
特别兴趣专场
ASH关于羟基脲治疗镰状细胞病的临床实践指南
次日04:30 – 05:00
企业演示： 公司与临床试验展厅
次日05:00 – 06:15
教育项目专场
在血栓与并发症之间：癌症抗凝治疗的新纪元
血红蛋白病与静脉血栓栓塞风险增加白血病移植后维持策略：目标患者、时机与原因
罕见侵袭性B细胞淋巴瘤：病理学家的挑战，临床医生的挑战
科学项目专场
中性粒细胞生物学的新前沿
血栓炎症
追溯血统：解码血细胞生产的胚胎波及其对疾病的贡献
次日05:00 – 06:30
口头报告专场
特别兴趣专场
ASH关于伴或不伴贫血的铁缺乏症诊断临床实践指南
ASH关于骨髓纤维化的临床实践指南
联合专场：通过人工智能推动血液学发展
次日05:00 – 06:35
联合科学项目专场
联合专场：骨髓衰竭与白血病胚系易感性的新兴格局
次日06:30 – 08:30
海报展厅欢迎招待会
次日07:30 – 09:00
特别兴趣专场
血液学纳入路径（HIP）口头报告 – 经典血液学
血液学纳入路径（HIP）口头报告 – 健康服务与结果研究
血液学纳入路径（HIP）口头报告 – 恶性血液学 I
血液学纳入路径（HIP）口头报告 – 恶性血液学 II
2025年12月7日（周日）
20:00 – 次日06:00
现场注册开放
20:00 – 22:00
ASH基金会竞走/跑步活动
医学教育者研讨会
21:00 – 22:00
企业演示： 产品展厅和行业展厅
“我如何治疗”专场
我如何将突变谱分析纳入AML治疗：基于年龄、复杂细胞遗传学及其他临床因素的考量
我如何将新型疗法纳入霍奇金淋巴瘤治疗：一线 vs. 复发
我如何优化血友病管理：新型治疗的作用
我如何治疗孕期血液科患者：母婴管理
我如何治疗难治性ITP的临床管理
科学家见面会
急性髓系白血病中的克隆演变
造血克隆：存在与否
淋巴瘤的分子靶向治疗
改善配型的新型血液输血遗传标记物
ASH 海报展（由Blood Neoplasia主办）
21:00 – 次日09:00
海报专场 II
22:30 – 23:45
教育项目专场
诊断和管理粘膜皮肤出血性疾病面临的挑战
我们的患者怀孕了：孕期及分娩时合并复杂血液学问题的产科患者共同管理
多发性骨髓瘤的治疗优化
骨髓衰竭领域的最新进展与现状
科学项目专场
利用止血相互作用组获取凝血蛋白的新见解和机制
科学研讨会
22:30 – 次日00:00
口头报告专场
特别兴趣专场
社区与学术血液学家如何促进患者参与临床试验作为医疗的一部分？
利用多发性骨髓瘤的真实世界数据用于监管目的
全程指导：引导镰状细胞病患者考虑基因治疗
ASH关于老年急性髓系白血病临床实践指南（更新）
22:30 – 次日00:05
联合科学项目专场
联合专场：克隆的游戏——从出生到衰老的造血演化
次日00:15 – 01:15
特别兴趣专场
Blood Advances推介：如何评审科学论文
ASH 海报展（由Blood Red Cells & Iron主办）
次日00:30 – 01:30
企业演示： 产品展厅和行业展厅
次日01:00 – 02:30
口头报告专场
ASH-EHA 联合研讨会
次日02:30 – 03:00
奖项公布 (Wallace H. Coulter血液学终身成就奖、ASH导师奖、ASH促进纳入卓越奖等)
次日03:00 – 05:00
全会科学专场
次日05:00 – 05:30
企业演示： 产品展厅和行业展厅
次日05:30 – 06:45
教育项目专场
动脉疾病与血液科医师
解读谜题：经典血液学会诊中的挑战
临床经典血液学的分子诊断：何时下单、下单何项、意义为何及何时转诊遗传学？
镰状细胞疗法：目标人群、方案选择、治疗时机与地点
新时代造血干细胞移植：相同供者、新预防方案、新型工程化（成人与儿科视角）
教育焦点专场
慢性髓系白血病面貌的变迁
科学焦点专场
异基因细胞治疗的排斥问题：证据、机制及克服新策略
次日05:30 – 07:00
口头报告专场
特别兴趣专场
ASH关于再生障碍性贫血的临床实践指南
早期教职工职业发展专场
ASH关于成人免疫性血小板减少症临床实践指南（更新）
次日07:00 – 09:00
海报展厅招待会
2025年12月8日（周一）
20:00 – 次日06:00
现场注册开放
21:00 – 22:00
ASH 海报展（由Blood Immunology & Cellular Therapy主办）
企业演示： 产品展厅和行业展厅
21:00 – 次日09:00
海报专场 III
22:00 – 23:00
E. Donnall Thomas讲座及颁奖
23:30 – 次日00:45
教育项目专场
血友病全生命周期管理更新：新型疗法/基因治疗/老年患者问题
免疫治疗的浪潮：我们在白血病、淋巴瘤及骨髓瘤领域的现状与未来
多发性骨髓瘤：适宜与非适宜患者的最佳诱导、巩固及维持治疗方案
急性髓系白血病的靶向治疗（三联及更多）
科学项目专场
修剪免疫反应：输血相关免疫调节的最新见解
教育焦点专场急性淋巴细胞白血病/淋巴母细胞淋巴瘤中的门冬酰胺酶：平衡新高效制剂的风险与获益
执业血液学家的输血医学：如何预防和治疗镰状细胞病中潜在的致命反应
科学焦点专场
连接转化科学与临床试验，全球变革伯基特淋巴瘤研究
设计与分析罕见血液病试验数据的创新统计技术
23:30 – 次日01:00
口头报告专场
特别兴趣专场
ASH-FDA 关于新批准疗法的联合研讨会 I
次日01:15 – 02:15
企业演示： 产品展厅和行业展厅
次日01:30 – 02:30
ASH 海报展（由Blood Global Hematology主办）
次日02:30 – 03:30
Ernest Beutler 讲座及颁奖
次日03:45 – 05:00
教育项目专场
血液学实践中基于生物学的铁毒性及铁过载管理
常见与罕见B细胞恶性肿瘤：慢性淋巴细胞白血病及罕见B细胞疾病有何新进展？
基因组学在儿童急性白血病风险分层中的应用
儿童白血病和淋巴瘤的免疫治疗导航：CAR-T细胞疗法、异基因造血干细胞移植——如何、何时及为何？
科学项目专场
髓系生成中谱系特异性基因表达程序的导向与脱轨机制
代谢在巨核细胞与血小板生物学中的关键作用
教育焦点专场免疫治疗时代与抗生素耐药性增长下，如何预防和管理免疫抑制患者的感染
科学焦点专场血液恶性肿瘤诊断中的表观基因组学前沿
次日03:45 – 05:15
口头报告专场
次日05:30 – 06:45
教育项目专场
具有临床意义的单克隆丙种球蛋白病
教育焦点专场
如何预防和管理免疫抑制患者在免疫治疗时代及抗生素耐药性增强背景下的感染
科学焦点专场
超越界限：模糊谱系急性白血病的研究为所有白血病解锁奥秘
次日05:30 – 07:00
口头报告专场
止血与血栓基础科学特别研讨会 (会后有招待会，仅限现场参会者)
特别兴趣专场
ASH镰状细胞病倡议：十年进展与对未来研究和护理的展望
ASH/FDA 关于新批准疗法的联合研讨会 II
次日07:00 – 09:00
海报展厅招待会
特别兴趣专场
镰状细胞病倡议中心招待会
次日07:00 – 08:30
ASH 止血与血栓学界交流招待会
特别兴趣专场
ASH 止血与血栓学界交流招待会
次日08:30 – 10:30
特别兴趣专场
血液学领域女性学者交流活动
2025年12月9日（周二）
20:00 – 次日01:00
现场注册开放
20:30 – 22:00
突破性研究专场
22:30 – 22:45
奖项公布 (William Dameshek奖、Henry M. Stratton奖章)
22:45 – 次日00:15
主席研讨会
次日00:15 – 00:30
商务会议
次日00:30 – 02:00
ASH精华回顾
次日02:00
现场会议结束
英文日程（UTC-5时区）
以下均为奥兰多时间，UTC-5
Saturday, December 6, 2025
7:00 a.m. – 6:00 p.m.
On-Site Registration Open
8:00 a.m. – 9:00 a.m.
How I Treat Sessions
How I Navigate Arterial Thrombosis: A Hematologist's Perspective
How I Treat Isolated CNS Relapse of B-ALL in the Era of Immunotherapy
How I Treat Multiple Myeloma Progression After Upfront Quadruplet Therapy
How I Treat The Balancing Act of Anticoagulant Management in Hemoglobinopathies
How I Use NGS in the Pre and Post-HSCT and Cell Therapy Setting
Meet the Scientist Sessions
Meet The Scientist: Genomics and Targeted Therapy in Pediatric Acute Leukemia
Meet The Scientist: Myeloma Biology and Therapy
Meet The Scientist: Never Go Into Transplant Waters Alone
Meet The Scientist: Somatic Genetic Rescue in Bone Marrow Failure Syndromes – Friend or Foe?
Corporate Presentations: Industry Forums
8:00 a.m. – 7:30 p.m.
Poster Session I
9:30 a.m. – 10:45 a.m.
Education Program Sessions
Bleeding Disorder of Unknown Cause—What Do We Know?
Immune Cytopenias: Addressing Challenges and Advancing Treatments
Scientific Program Sessions
Dissecting Enhancer Function in Hematopoietic Development and Disease
Exploring the Origins of Multiple Myeloma: Germline Predisposition and Early DeregulationsIron and Heme Metabolism and Its Considerations in Understanding Pathophysiology and Therapy
Strategies To Improve Outcomes After Hematopoietic Cell Transplantation and Adoptive Cellular Therapies
Special Interest Sessions
Leveraging Genetic Diversity in Preclinical Discovery to Guide Precision Medicine
9:30 a.m. – 11:00 a.m.
Oral Abstract Sessions
Special Interest Sessions
Leveraging Real-World Data in Sickle Cell Disease to Identify and Study Specific Cohorts of Interest
11:15 a.m. – 12:15 p.m.
Special Interest Sessions
Blood Presents: How to get Published in a Peer Review Journal
ASH Poster Walk Hosted by Blood Vessels, Thrombosis & Hemostasis
11:30 a.m. – 12:30 p.m.
Corporate Presentations: Product Theaters and Industry Theaters
12:00 noon – 1:30 p.m.
Oral Abstract Sessions
12:30 p.m. – 1:30 p.m.
Ham-Wasserman Lecture
2:00 p.m. – 3:15 p.m.
Education Program Sessions
Complementopathies: Modern Diagnosis and Management
The Changing Landscape of the Care of Patients With Immune-Mediated and Congenital TTP
Down the Rabbit Hole: An Update on Histiocytic Disorders
Frontline Incorporation of Immune Targeting Agents in B-ALL: Triumphs and Challenges
Now Is the Time to Improve Outcomes in Diffuse Large B-Cell Lymphoma
Scientific Program Sessions
Flipping the Switch: Fetal Hemoglobin Reactivation for Treating Hemoglobin Disorders – From Mechanism to Therapy
Innovative Models of Lymphoma
2:00 p.m. – 3:30 p.m.
Oral Abstract Sessions
Special Interest Sessions
ASH Clinical Practice Guidelines on Hydroxyurea for Sickle Cell Disease
3:30 p.m. – 4:00 p.m.
Corporate Presentations: Company and Clinical Trial Showcases
4:00 p.m. – 5:15 p.m.
Education Program Sessions
Between Clots and Complications: A New Era of Anticoagulation in Cancer
Hemoglobinopathies and Increased Risk of Venous Thromboembolism
Post-SCT Maintenance Strategies in Leukemia: Who, When, and Why?
Rare Aggressive B-Cell Lymphomas: Challenge for a Pathologist, Challenge for a Clinician
Scientific Program Sessions
New Frontiers in Neutrophil Biology
Thromboinflammation
Tracing Bloodlines: Decoding Embryonic Waves of Blood Cell Production and Their Contribution to Disease
4:00 p.m. – 5:30 p.m.
Oral Abstract Sessions
Special Interest Sessions
ASH Clinical Practice Guidelines on Diagnosis of Iron Deficiency with and without Anemia
ASH Clinical Practice Guidelines on Myelofibrosis
Joint Session: Advancing Hematology Through Artificial Intelligence
Joint Scientific Program Sessions
Joint Sessions: The Emerging Landscape of Germline Predisposition to Bone Marrow Failure and Leukemia
5:30 p.m. – 7:30 p.m.
Welcome Reception in Poster Hall
6:30 p.m. – 8:00 p.m.
Special Interest Sessions
Hematology Inclusion Pathway (HIP) Oral Presentations – Classical Hematology
Hematology Inclusion Pathway (HIP) Oral Presentations – Health Services Outcomes
Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology I
Hematology Inclusion Pathway (HIP) Oral Presentations – Malignant Hematology II
Sunday, December 7, 2025
7:00 a.m. – 5:00 p.m.
On-Site Registration Open
7:00 a.m. – 9:00 a.m.
ASH Foundation Run/Walk
Medical Educators Symposium
8:00 a.m. – 9:00 a.m.
Corporate Presentations: Product Theaters and Industry Theaters
How I Treat Sessions
How I Incorporate Mutational Profiling into Treatment of AML: Considerations Based on Age, Complex Cytogenetics, and Other Clinical Factors
How I Incorporate Novel Therapies into Hodgkin Lymphoma Treatment: Frontline vs. Relapse
How I Optimize Hemophilia Management: The Role of Novel Treatments
How I Treat Baby on Board: Managing the Hematological Pregnant Patient
How I Treat Clinical Management of Refractory ITP
Meet the Scientist Sessions
Meet The Scientist: Clonal Evolution in Acute Myeloid Leukemia
Meet The Scientist: Hematopoietic Clones - To Be or Not to Be
Meet the Scientist: Molecularly Targeted Therapies in Lymphoma
Meet The Scientist: Novel Genetic Markers in Blood Transfusion for Improved Matching
ASH Poster Walk Hosted by Blood Neoplasia
8:00 a.m. – 8:00 p.m.
Poster Session II
9:30 a.m. – 10:45 a.m.
Education Program Sessions
Challenges in Diagnosing and Managing Mucocutaneous Bleeding Disorders
Our Patient Is Pregnant: Comanaging Obstetric Patients With Complex Hematologic Issues During Their Pregnancy and Delivery
Treatment Refinement in Multiple Myeloma
What's New and Current in the World of Bone Marrow Failure
Scientific Program Sessions
Harnessing The Hemostasis Interactome for Novel Insights and Mechanisms of Coagulation Proteins
Scientific Symposia
9:30 a.m. – 11:00 a.m.
Oral Abstract Sessions
Special Interest Sessions
How Can Community-Based and Academic Hematologists Foster Clinical Trial Participation as Part of Patient Care?
Leveraging Real-World Data in Multiple Myeloma for Regulatory Purposes
To, Through and Thereafter: Guiding Sickle Cell Disease Patients Considering Gene Therapy
Updated ASH Clinical Practice Guidelines on Acute Myeloid Leukemia (AML) in Older Adults
9:30 a.m. – 11:05 a.m.
Joint Scientific Program Sessions
Joint Sessions: Game of Clones – The Evolution of Hematopoiesis from Birth to Aging
11:15 a.m. – 12:15 p.m.
Special Interest Sessions
Blood Advances Presents: How to Peer Review a Scientific Paper
ASH Poster Walk Hosted by Blood Red Cells & Iron
11:30 a.m. – 12:30 p.m.
Corporate Presentations: Product Theaters and Industry Theaters
12:00 noon – 1:30 p.m.
Oral Abstract Sessions
12:30 p.m. – 1:30 p.m.
ASH-EHA Joint Symposium
1:30 p.m.– 2:00 p.m.
Announcement of Awards:
Wallace H. Coulter Award for Lifetime Achievement in Hematology, ASH Mentor Award, ASH Advancing Inclusive Excellence Award, et al.
2:00 p.m. – 4:00 p.m.
Plenary Scientific Session
4:00 p.m. – 4:30 p.m.
Corporate Presentations: Company and Clinical Showcases
11:15 a.m. – 12:15 p.m.
Special Interest Sessions
Blood Advances Presents: How to Peer Review a Scientific Paper
ASH Poster Walk Hosted by Blood Red Cells & Iron
11:30 a.m. – 12:30 p.m.
Corporate Presentations: Product Theaters and Industry Theaters
12:00 noon – 1:30 p.m.
Oral Abstract Sessions
12:30 p.m. – 1:30 p.m.
ASH-EHA Joint Symposium
1:30 p.m.– 2:00 p.m.
Announcement of Awards:
Wallace H. Coulter Award for Lifetime Achievement in Hematology, ASH Mentor Award, ASH Advancing Inclusive Excellence Award, et al.
2:00 p.m. – 4:00 p.m.
Plenary Scientific Session
4:00 p.m. – 4:30 p.m.
Corporate Presentations: Company and Clinical Showcases
4:30 p.m. – 5:45 p.m.
Education Program Sessions
Arterial Disease and the Hematologist
Decoding the Enigma: Challenges in Classical Hematology Consultations
Molecular Diagnostics for Clinical Classical Hematologists: When to Order, What to Order, What It Means, and When to Refer to Genetics?
Sickle Cell Therapies: The Who, What, When, and Where
New Age Hematopoietic Stem Cell Transplantation: Same Donors, New Prophylaxis, Novel Engineering (Adult and Pediatric Perspectives)
Education Spotlight Sessions
The Changing Face of Chronic Myelogenous Leukemia
Scientific Spotlight Sessions
The Issue of Rejection of Allogeneic Cellular Therapies: Evidence, Mechanisms, and Novel Strategies to Overcome It
4:30 p.m. – 6:00 p.m.
Oral Abstract Sessions
Special Interest Sessions
ASH Clinical Practice Guidelines on Aplastic Anemia
Early Faculty Career Development Session
Updated ASH Clinical Practice Guidelines on Immune Thrombocytopenia (ITP) in Adults
6:00 p.m. – 8:00 p.m.
Poster Hall Reception
Monday, December 8, 2025
7:00 a.m. – 5:00 p.m.
On-Site Registration Open
8:00 a.m. – 9:00 a.m.
ASH Poster Walk Hosted by Blood Immunology & Cellular Therapy
Corporate Presentations: Product Theaters and Industry Theaters
8:00 a.m. – 8:00 p.m.
Poster Session
9:00 a.m. – 10:00 a.m.
E. Donnall Thomas Lecture and Prize
10:30 a.m. – 11:45 a.m.
Education Program Sessions
Update in Hemophilia Across the Lifespan: Novel Therapies/Gene Therapy/Issues in Older Patients
Invasion of the Immunotherapies: Where We Are and Where We Are Going in Leukemia, Lymphoma, and Myeloma
Multiple Myeloma: What Is the Best Induction, Consolidation, and Maintenance for Fit vs. Non-Fit
Targeted Therapy for AML (Triplets and More)
Scientific Program Sessions
Trimming the Immune Response: Cutting-Edge Insights into Transfusion-Related Immunomodulation
Education Spotlight Sessions
Asparaginase in ALL/LBL: Balancing the Risk/Benefit of New Efficacious Preparations
Transfusion Medicine for Practicing Hematologists: How to Prevent and Treat Potentially Fatal Reactions in Sickle Cell Disease
Scientific Spotlight Sessions
Bridging Translational Science and Clinical Trials to Transform Burkitt Lymphoma Research Globally
Creative and Novel Statistical Techniques to Design and Analyze Data for Trials Focused on Rare Hematologic Diseases
10:30 a.m. – 12:00 noon
Oral Abstract Sessions
Special Interest Sessions
ASH-FDA Joint Symposium on Newly Approved Therapies I
12:15 p.m. – 1:15 p.m.
Corporate Presentations: Product Theaters and Industry Theaters
12:30 p.m. – 1:30 p.m.
ASH Poster Walk Hosted by Blood Global Hematology
1:30 p.m. – 2:30 p.m.
Ernest Beutler Lecture and Prize
2:45 p.m. – 4:00 p.m.
Education Program Sessions
Biology-Based Management of Iron Toxicity and Overload in Hematology Practice
B-Cell Malignancies Common and Rare: What's New in Chronic Lymphocytic Leukemia and Rare B-Cell Disorders?
Genomics in Pediatric Acute Leukemia Risk Stratification
Navigating Immunotherapies in Pediatric Leukemia and Lymphoma: CAR-Ts, allo-HSCT - How, When, and Why?
Scientific Program Sessions
Mechanisms that Direct and Derail Lineage-Specific Gene Expression Programs in Myelopoiesis
The Critical Role of Metabolism in Megakaryocyte and Platelet Biology
Education Spotlight Sessions
How to Prevent and Manage Infections in Immunocompromised Patients in the Era of Immunotherapy and Growing Antibiotic Resistance
Scientific Spotlight Sessions
Epigenomic Frontiers in the Diagnosis of Hematological Malignancies
2:45 p.m. – 4:15 p.m.
Oral Abstract Sessions
4:30 p.m. – 5:45 p.m.
Education Program Sessions
Monoclonal Gammopathies of Clinical Significance
Education Spotlight Sessions
How to Prevent and Manage Infections in Immunocompromised Patients in the Era of Immunotherapy and Growing Antibiotic Resistance
Scientific Spotlight Sessions
Transcending Boundaries: Study of Ambiguous Lineage Acute Leukemia Unlocks Mysteries for All Leukemias
4:30 p.m. – 6:00 p.m.
Oral Abstract Sessions
Special Symposium on the Basic Science of Hemostasis and Thrombosis (reception to follow for in-person participants)
Special Interest Sessions
ASH’s SCD Initiative: 10 Years of Progress and a Look to the Future of Sickle Cell Disease Research and Care
ASH/FDA Joint Symposium on Newly Approved Therapies II
6:00 p.m. – 8:00 p.m.
Poster Hall Reception
Special Interest Sessions
Center for Sickle Cell Disease Initiatives Reception
6:00 p.m. – 7:30 p.m.
ASH Networking Reception for the Hemostasis and Thrombosis Community
Special Interest Sessions
ASH Hemostasis and Thrombosis Community Networking Reception
7:30 p.m. – 9:30 p.m.
Special Interest Sessions
Women in Hematology Networking Event
Tuesday, December 9, 2025
7:00 a.m. – 12:00 noon
On-Site Registration Open
7:30 a.m. – 9:00 a.m.
Late-Breaking Abstracts Session
9:30 a.m. – 9:45 a.m.
Announcement of Awards:
William Dameshek Prize and Henry M. Stratton Medal
9:45 a.m. – 11:15 a.m.
Presidential Symposium
11:15 a.m. – 11:30 a.m.
Business Meeting
11:30 a.m. – 1:00 p.m.
Best of ASH
1:00 p.m.
In-person Meeting Concludes
https://www.hematology.org/meetings/annual-meeting/schedule-and-program/schedule-at-a-glance
排版编辑：Grady
苏公网安备32059002004080号
